Member Board of Directors @ (January 2022 - Present)
Founder @ (January 2003 - Present)
CEO @ (January 2017 - January 2019)
SVP Global Sales and OEM @ (January 2013 - January 2017)
President and GM - NPWT Corp- Div. Ohio Medical @ (January 2010 - January 2012)
VP New Business Ventures and OEM @ (January 2008 - January 2010)
SVP Global Sales and Marketing @ Medwave (January 2006 - January 2008)
VP Marketing and Business Development @ (January 2002 - January 2006)
VP Domestic Sales, Marketing and Global OEM Business Development @ (January 1996 - January 2001)
Rocco Morelli Education
Loyola University of Chicago
BBA ( Finance-International)
1987-1991
Maine South High School
Rocco Morelli Skills
Molecular Diagnostics
Genome Editing
Genetics
Biotechnology
Market Development
Strategy
Medical Devices
Capital Equipment
Operating Room
Product Development
Cross-functional Team Leadership
Strategic Partnerships
New Business Development
B2B
Business Development
Start-ups
Clinical Research
Team Building
International Sales
Healthcare
FDA
Product Launch
Sales Management
Product Management
Sales Operations
Cardiology
Disposables
Sales Force Development
Direct Sales
Marketing
Sales
Management
Competitive Analysis
Sales Presentations
Selling
Leadership
Key Account Management
Sales Process
Forecasting
P&L Management
Start Ups
Strategic Planning
Cross Functional Team Leadership
Business Analysis
Crossfunctional Team Leadership
Change Management
Rocco Morelli Summary
Rocco Morelli, based in Lincolnshire, IL, US, is currently a Chief Executive Officer at Recombinetics. Rocco Morelli brings experience from previous roles at Recombinetics, Acceligen, ROC ADVISORS, LLC and Ulisse BioMed. Rocco Morelli holds a 1987 - 1991 BBA in Finance-International @ Loyola University of Chicago. With a robust skill set that includes Molecular Diagnostics, Genome Editing, Genetics, Biotechnology, Market Development and more. Rocco Morelli has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Rocco Morelli?
Find contact details for 700 million professionals.